PMC Biogenix to build new Armoslip facility in Gyeongju, South Korea

PMC Biogenix announced the construction of a new Armoslip facility in Gyeongju, South Korea, increasing production capacity by 50%. Construction will begin in late 2024 with new supply available by mid-2026.

“We are excited to announce plans to build a new facility in Gyeongju. This investment will allow us to significantly increase production capacity to meet growing customer demand for our Armoslip products.”koreanewswire.co.kr

• 2 sources
• koreanewswire.co.krPMC Biogenix Announces Expansion and Restructure - Korea NewswirePMC BiogenixJun 23, 2024
• newswire.co.krPMC Biogenix Announces Expansion and Restructure - 뉴스와이어PMC BiogenixJun 23, 2024

Summarized from public sources; check the original articles before acting on it.